icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
PHARMACOKINETIC INTERACTIONS BETWEEN THE HCV PROTEASE INHIBITOR BOCEPREVIR AND SIROLIMUS IN HEALTHY SUBJECTS
 
 
  Reported by Jules Levin
EASL 2013 April 24-28 2013 Amsterdam
 
Ellen GJ Hulskotte1, Hwa-Ping Feng2, Fengjuan Xuan2, Wen Hong Lin2, Yali Zhu2, Scott Rasmussen3, Joan R Butterton2 1Merck Sharp & Dohme Corp., Oss, The Netherlands; 2Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA; 3Celerion, Lincoln, NE, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif